Peter Vanderslice, PhD, Senior Investigator and Director, MCRL, Molecular Cardiology Research, was highlighted in a recent announcement from 7 Hills Pharma,...
Pages tagged: molecular cardiology
Houston, TX, May 20, 2022 – Together with The University of Texas MD Anderson Cancer Center (“MD Anderson”) and Texas...
Grant from the NIH NIDDK to Advance Collaboration to Develop Treatments for Inflammatory Disease HOUSTON, TX, November 10, 2020 –...
A promising molecular technology co-invented by scientists at the Texas Heart Institute and 7 Hills could soon enhance the effectiveness...
A promising technology invented at the Texas Heart Institute is one step closer to being tested in a clinical study...
